首頁(yè)
關于(yu)我(wo)們
創新(xin)研髮(fa)
産(chan)品(pin)中(zhong)心
學(xué)術(shù)交流
新(xin)聞資(zi)訊
投(tou)資(zi)者關係(xi)
人(ren)才(cai)招聘
聯(lian)係(xi)我(wo)們
員(yuan)工(gong)專(zhuan)區(qu)
我(wo)武追溯碼
Academic Communication
綜述性研究 臨牀(chuang)觀察研究
2014-Efficacy and safety of house dust mite sublingual immunotherapy in monosensitized and polysensitized children with respiratory allergic diseases. (Int Forum Allergy Rhinol, IF=2.521)
2014-Efficacy and safety of sublingual immunotherapy in children aged 3–13 years with allergic rhinitis. (Am J Rhinol Allergy, IF=2.015)
2016-Increased Expression of miR-146a in Children With Allergic. (Allergy Asthma Immunol Res, IF=5.026)
2016-The effects of house dust mite sublingual immunotherapy in patients according to duration. (Int Forum Allergy Rhinol, IF=2.521)
2017-Clinical evaluation for sublingual immunotherapy with Dermatophagoides farinae drops in adult patients with allergic asthma. (Ir J Med Sci, IF=1.031)
2017-Nonadherence to sublingual immunotherapy in allergic rhinitis a real-life analysis. (Int Forum Allergy Rhinol, IF=2.521)
2017-The efficacy and safety of sublingual immunotherapy in children and adult patients with allergic rhinitis. (Allergol Immunopathol, IF=1.64)
2018-Efficacy and safety of sublingual immunotherapy with Dermatophagoides farinae drops in pre-school and school age children with allergic rhinitis. (Allergol Immunopathol, IF=1.64)
2019-Long-Term Efficacy of Sublingual Mite Immunotherapy in Monosensitized and Polysensitized Children with Allergic Rhinitis: A 7-Year Prospective Study. (Int Arch Allergy Immunol, IF= 2.932)
2014-Efficacy and safety of sublingual immunotherapy in children aged 3–13 years with allergic rhinitis
